TEMPLE TERRACE, Fla. — A research center in Temple Terrace is one of 140 places across the country chosen to test four new COVID-19 treatments.
“I found this study that was providing treatment and also I think it’s really important to be part of research and further the information that we have so we better understand the disease and the treatments," said Yesena Artigas.
Artigas tested positive for COVID-19 a few weeks ago and decided to use it as an opportunity to participate in a study held by Moore Clinical Research.
The study is looking for people 18 and old who are experiencing mild to moderate symptoms and are not in the hospital.
The study is testing treatments that come as a pill, an inhalant, a rapid infusion and a shot.
“What the study is trying to do is basically flood your immune system with antibodies already," Michael Bland, Vice President Moore Clinical Research said. "So you’re already developing antibodies but what we’re doing is giving you a booster of antibodies, to fight off that virus.”
Next week the research clinic will begin to study a new pill form.
“That’s going to be a major step because if we can find an effective pill then I think we can get to the point where it’s like malaria. Take it to prevent it,” said Dr. George Monlux, Principal Investigator.
The clinic is still looking for more volunteers.
- Must be 18+ years of age
- Must have mild to moderate symptoms of COVID 19
- Must test positive for COVID 19 - on-site testing available
- Compensation up to $2,000 for time and travel
- Study-related phone and in-clinic visits with Physician at no cost
- No insurance is needed
Participants who are eligible for the infusion treatment will have a risk factor that put them at higher risk of progressing to severe COVID-19. That includes being age 60 or older, being a current smoker, or having one of the following conditions: chronic lung, kidney, or liver disease; obesity; hypertension; cardiovascular disease; diabetes; or current cancer or immunosuppression
Participants eligible for the other ages may be at higher or lower risk for progressing to severe COVID-19.